CoMind
CoMind is developing non-invasive neuromonitoring technology aimed at revolutionizing clinical brain monitoring and improving treatment for brain disorders. The company emphasizes innovative, high-tech solutions within a regulated environment, fostering a collaborative culture that integrates AI into their workflows.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2018
CoMind Technologies is dedicated to transforming neurotechnology with its innovative non-invasive solutions for measuring and treating brain functions. The company aims to enhance patient outcomes through advanced technology that enables clinicians to access critical neurophysiological signals in a streamlined manner. By optimizing brain monitoring, CoMind is at the forefront of redefining clinical care across various medical settings. Their mission highlights a commitment to improving healthcare practices through the application of cutting-edge technology in neurodiagnostics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CoMind.
No drill required: London’s CoMind raises €85 million to replace invasive brain monitoring
Oct 20, 2025